Plain-English translation of NCT06980103 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a web-based decision aid called RAI Decisions to help patients with intermediate-risk thyroid cancer make treatment decisions. Some patients will use this new tool, which provides detailed information about risks, benefits, and personal values related to radioactive iodine treatment. Other patients will receive standard educational materials from the American Cancer Society website to compare which approach helps people feel more confident in their choice.
Many patients with intermediate-risk thyroid cancer face a genuinely uncertain decision about whether this medication will help them, since the benefits vary from person to person. This tool aims to help patients feel more informed and supported when talking with their doctors about this important choice.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly placed into one of two groups. One group will access the web-based decision tool, which walks you through information about your diagnosis, treatment options, potential risks and benefits, and helps you clarify your personal values and preferences. The other group will receive a link to standard educational materials from the American Cancer Society website. You will need to be available to complete study activities throughout the study and may be contacted to provide feedback about your experience.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States